BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26611918)

  • 1. Enkephalin analogues with N-phenyl-N-(piperidin-2-ylmethyl)propionamide derivatives: Synthesis and biological evaluations.
    Deekonda S; Cole J; Sunna S; Rankin D; Largent-Milnes TM; Davis P; BassiriRad NM; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem Lett; 2016 Jan; 26(1):222-7. PubMed ID: 26611918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.
    Deekonda S; Wugalter L; Rankin D; Largent-Milnes TM; Davis P; Wang Y; Bassirirad NM; Lai J; Kulkarni V; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4683-8. PubMed ID: 26323872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel enkephalin analogues that have enhanced opioid activities at both mu and delta opioid receptors.
    Lee YS; Petrov R; Park CK; Ma SW; Davis P; Lai J; Porreca F; Vardanyan R; Hruby VJ
    J Med Chem; 2007 Nov; 50(22):5528-32. PubMed ID: 17927164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of 5-substituted tetrahydronaphthalen-2yl-methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands.
    Deekonda S; Wugalter L; Kulkarni V; Rankin D; Largent-Milnes TM; Davis P; Bassirirad NM; Lai J; Vanderah TW; Porreca F; Hruby VJ
    Bioorg Med Chem; 2015 Sep; 23(18):6185-94. PubMed ID: 26299827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design synthesis and structure-activity relationship of 5-substituted (tetrahydronaphthalen-2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands.
    Deekonda S; Rankin D; Davis P; Lai J; Vanderah TW; Porecca F; Hruby VJ
    Bioorg Med Chem; 2016 Jan; 24(2):85-91. PubMed ID: 26712115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of potent μ and δ opioid agonists with high lipophilicity.
    Lee YS; Kulkarani V; Cowell SM; Ma SW; Davis P; Hanlon KE; Vanderah TW; Lai J; Porreca F; Vardanyan R; Hruby VJ
    J Med Chem; 2011 Jan; 54(1):382-6. PubMed ID: 21128594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of cyclic lanthionine enkephalin analogues: delta-opioid receptor selective ligands.
    Rew Y; Malkmus S; Svensson C; Yaksh TL; Chung NN; Schiller PW; Cassel JA; DeHaven RN; Taulane JP; Goodman M
    J Med Chem; 2002 Aug; 45(17):3746-54. PubMed ID: 12166947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of biphalin. The synthesis and biological activities of new analogues with modifications in positions 3 and 4.
    Misicka A; Lipkowski AW; Horvath R; Davis P; Porreca F; Yamamura HI; Hruby VJ
    Life Sci; 1997; 60(15):1263-9. PubMed ID: 9096243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.
    Agnes RS; Lee YS; Davis P; Ma SW; Badghisi H; Porreca F; Lai J; Hruby VJ
    J Med Chem; 2006 May; 49(10):2868-75. PubMed ID: 16686530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor binding and biological activity of bivalent enkephalins.
    Costa T; Wüster M; Herz A; Shimohigashi Y; Chen HC; Rodbard D
    Biochem Pharmacol; 1985 Jan; 34(1):25-30. PubMed ID: 2981528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid bivalent ligands with opiate and enkephalin pharmacophores.
    Portoghese PS; Larson DL; Ronsisvalle G; Schiller PW; Nguyen TM; Lemieux C; Takemori AE
    J Med Chem; 1987 Nov; 30(11):1991-4. PubMed ID: 2444704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties.
    Fujita Y; Tsuda Y; Li T; Motoyama T; Takahashi M; Shimizu Y; Yokoi T; Sasaki Y; Ambo A; Kita A; Jinsmaa Y; Bryant SD; Lazarus LH; Okada Y
    J Med Chem; 2004 Jul; 47(14):3591-9. PubMed ID: 15214786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
    Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
    Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent biphalin analogs with µ/δ mixed opioid activity: in vivo and in vitro biological evaluation.
    Costante R; Pinnen F; Stefanucci A; Mollica A
    Arch Pharm (Weinheim); 2014 May; 347(5):305-12. PubMed ID: 24798820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.